Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Modulatory Roles of AHR, FFAR2, FXR, and TGR5 Gene Expression in Metabolic-Associated Fatty Liver Disease and COVID-19 Outcomes

19 Jun 2024

Abstract excerpt

Metabolic-associated fatty liver disease (MAFLD) is a risk factor for severe COVID-19. This study explores the potential influence of gut hormone receptor and immune response gene expression on COVID-19 outcomes in MAFLD patients. Methods: We investigated gene expression levels of AHR, FFAR2, FXR, and TGR5 in patients with MAFLD and COVID-19 compared to controls. We examined associations between gene expression...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Liver Disease Diagnosis and Treatment
Share to Pancreatitis Pathology and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38932276
DOI: 10.3390/v16060985

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Modulatory Roles of AHR, FFAR2, FXR, and TGR5 Gene Expression in Metabolic-Associated Fatty Liver Disease and COVID-19 OutcomesPMID 38932276Read ↗

Modulatory Roles of AHR, FFAR2, FXR, and TGR5 Gene Expression in MAFLD and COVID-19 OutcomesSemantic proximity Read ↗

Orchestration of Gut–Liver-Associated Transcription Factors in MAFLD: From Cross-Organ Interactions to Therapeutic InnovationSemantic proximity Read ↗

Genetic Predictors of Comorbid Course of COVID-19 and MAFLD: A Comprehensive AnalysisSemantic proximity Read ↗

Genetic Predictors of Comorbid Course of COVID-19 and MAFLD: A Comprehensive AnalysisSemantic proximity Read ↗

Demonstration of the impact of COVID-19 on metabolic associated fatty liver disease by bioinformatics and system biology approachSemantic proximity Read ↗

Causal relationship between key genes and metabolic dysfunction‐associated fatty liver disease risk mediated by immune cells: A Mendelian randomization and mediation analysisSemantic proximity Read ↗

Transcription factors, metabolic dysfunction-associated fatty liver disease, and therapeutic implicationsSemantic proximity Read ↗

Innate Immune Receptors: Key Regulators of Metabolic Disease ProgressionSemantic proximity Read ↗

Circulating Lipids Predict Mortality and Drive Immune Gene Regulation in Acute-on-Chronic Liver FailureSemantic proximity Read ↗

Identification of EGR1 as a Key Diagnostic Biomarker in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Through Machine Learning and Immune AnalysisSemantic proximity Read ↗

Protease-Activated Receptor 2 and Its Role in the Progression from Metabolic-Disfunction Associated Steatotic Liver Disease to Hepatocellular CarcinomaSemantic proximity Read ↗

Mechanistically linked serum miRNAs distinguish between drug induced and fatty liver disease of different gradesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.